logo
Dallas Housing Market Turns, Number of Homes for Sale Go 'Through the Roof'

Dallas Housing Market Turns, Number of Homes for Sale Go 'Through the Roof'

Newsweek3 days ago
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
The Dallas-Fort Worth housing market is experiencing a sharp shift, with the number of homes for sale hitting levels not seen in more than a decade and price growth starting to reverse.
The surge in available homes in Dallas marks a stark contrast to the pandemic-era frenzy that saw bidding wars, record price growth, and a flood of out-of-state buyers, according to housing experts.
Analysts, meanwhile, point to a combination of factors behind the turnaround: more sellers re-entering the market after holding off during periods of interest rate uncertainty, a wave of new construction, and slowing demand as affordability pressures mount. With prices slipping year-over-year, they remain significantly higher than pre-pandemic levels.
Active listings in Dallas-Fort Worth reached almost 32,000 last month, according to Nick Gerli, CEO of real estate data consulting firm Reventure. That is around 60 percent more than the July average of 20,000 going back to 2017.
Gerli described the current supply situation as "through the roof" in a post on X earlier this month, noting that the inventory surge is "happening pretty much everywhere in DFW."
"[This is] the most selection the market has had since the tail end of the last downturn in 2011–12," Gerli wrote. Currently in Dallas, Zillow says house prices are down 4.6 percent over the last year, with an average value of $315,056.
Looking ahead, Reventure forecasts a 7.8 percent drop in Dallas-Fort Worth home values over the next 12 months. On X, Gerli described the market as still "overvalued" by 22 percent and suggested prices may continue to fall for a couple of years before hitting bottom.
Housing Price Drop 'Isn't Totally Surprising'
For Harrison Polsky, a Dallas-based agent with Douglas Elliman and principal of Catēna Homes, the current cooling follows a period of unusually rapid growth. Between March 2017 and a peak in May 2025, home values in Dallas grew from $185,000 to $331,000, according to Zillow.
"What's happening in Dallas-Fort Worth isn't totally surprising," Polsky told Newsweek. "We had such an explosive run-up in prices during the pandemic and people moving here in droves, low interest rates, tons of investor activity. Now we're seeing the market catch its breath. A lot of that outside momentum has cooled, and buyers are just being more cautious. It's not just Dallas—it's happening in other Texas cities too, but we're feeling it here more because we had such a sharp rise to begin with. This is more of a recalibration than a collapse."
Some increase in supply is normal during the warmer months, but Polsky said the current surge goes beyond seasonal patterns.
"Some of this is definitely seasonal—we always see more homes hit the market in spring and summer," he explained. "But this year feels different. Sellers who were holding off last year because of rate uncertainty are now listing, hoping to catch buyers before prices dip further. At the same time, we're seeing more new construction coming online, and fewer out-of-state buyers compared to the pandemic peak. So, it's not just a seasonal bump—it's a shift toward a market that's getting more competitive."
Stock image/file photo: The Dallas skyline taken in late afternoon.
Stock image/file photo: The Dallas skyline taken in late afternoon.
GETTY
Buyer's Market: Prices Drops to Continue
Polsky sees Reventure's 7 to 8 percent drop forecast as plausible in certain parts of the metro.
"A 7 to 8 percent drop might sound dramatic, but in context, it's not totally out of bounds—especially in neighborhoods where prices got inflated quickly," he said. "That said, I don't think every area will see that kind of dip. Some neighborhoods with strong schools, walkability, or limited inventory will probably hold up better. If rates stay high and inventory keeps climbing, sure, we could get close to that number. But I'd call that the higher end of the range—not a baseline for the whole market."
For prospective buyers, the shift could bring long-awaited relief from years of overheated conditions.
"If you're a buyer, this is probably the best shot you've had in years to negotiate," Polsky said. "Prices are softer, sellers are more flexible, and you're not having to compete in crazy bidding wars like before. I always tell clients: if you're planning to stay in the home for a while, and you find the right fit, go for it. Waiting for the 'perfect' bottom can backfire—especially if rates tick up again. This is a market where patience helps, but hesitation could cost you the right opportunity."
Sellers, however, could be facing a more challenging environment.
"You've got to be honest with yourself about today's market," Polsky said. "Gone are the days of throwing out a sky-high asking price and getting multiple offers overnight. Buyers are smarter and have way more options now. The best thing a seller can do is price right from the start, make the home look its absolute best, and be open to conversations. You don't need to give the house away, but you do need to show you're serious about selling. Presentation and realistic expectations are everything right now."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bills-Cowboys trade proposal pairs Joey Bosa with $24M edge rusher, 52-sack machine
Bills-Cowboys trade proposal pairs Joey Bosa with $24M edge rusher, 52-sack machine

Yahoo

time30 minutes ago

  • Yahoo

Bills-Cowboys trade proposal pairs Joey Bosa with $24M edge rusher, 52-sack machine

Bills-Cowboys trade proposal pairs Joey Bosa with $24M edge rusher, 52-sack machine originally appeared on The Sporting News The Dallas Cowboys and Micah Parsons appear to be locked in a standoff. The two sides are not on good terms at the moment, largely due to team owner Jerry Jones. Jones has a history of negotiating contracts with simple handshake deals, but Parsons wasn't a fan of that approach when it was presented to him. 'The fact that Jerry Jones and the Cowboys believe they can negotiate a 9-figure extension with Micah Parsons without involving his agent says everything about the current state of the franchise. This entire situation is laughable from the Dallas side. It could've — and should've — been avoided. But instead, the Cowboys operated with pure arrogance, foolishness and stubbornness,' NFL insider Jordan Schultz posted. The situation escalated to the point where Parsons, clearly frustrated, formally requested a trade. 'Still I stayed quiet but again after repeated shots at myself and all the narratives I have made a tough decision I no longer want to play for the Dallas Cowboys. My trade request has been submitted to Stephen Jones personally,' Parsons posted. While Jerry Jones has urged Cowboys fans to remain calm, Pro Football Talk's Mike Florio believes the opportunity to make things right may already be gone. 'The ship, we're told, quite possibly has sailed. Parsons quite possibly will reject any offer he receives from the Cowboys on a long-term deal, because he no longer wants one,' Florio wrote. Follow The Sporting News on WhatsApp With a trade now appearing to be the only viable path forward, Eric Edholm has predicted a potential blockbuster deal sending Parsons to the Buffalo Bills. 'But the Bills need to have tunnel vision on winning a Super Bowl now, having come achingly close multiple times over the past several years. Joey Bosa was a big-name addition this offseason, and Greg Rousseau is a top-tier rusher, but adding Parsons would take this defense to the next level,' Edholm wrote. 'When the Bills have needed a crucial defensive stop in several key games the past few years, especially in the playoffs, they have come up short more often than not. Adding one more elite defender could be the difference between a title and another missed opportunity for one.' Buffalo's defense has fallen short in clutch moments for years, and Parsons could be the missing piece that finally gets them over the hump. A move like this would be a dream scenario for Josh Allen and could instantly elevate the Bills into Super Bowl favorites.

The Hidden Math That Makes Some Australians Poorer for Working Harder
The Hidden Math That Makes Some Australians Poorer for Working Harder

Epoch Times

time39 minutes ago

  • Epoch Times

The Hidden Math That Makes Some Australians Poorer for Working Harder

AD It may seem counterintuitive, but working longer hours can make you less money, the e61 Institute says. A pile of bills in Brisbane, Australia, on Oct. 30, 2013. AAP Image/Dan Peled 8/13/2025 | Updated: 8/13/2025 Not so long ago, working harder was thought to guarantee you were better off. Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio. Author's Selected Articles

Indoco Remedies gets USFDA nod for generic Rivaroxaban tablets; eyes growth in US Market
Indoco Remedies gets USFDA nod for generic Rivaroxaban tablets; eyes growth in US Market

Business Upturn

time42 minutes ago

  • Business Upturn

Indoco Remedies gets USFDA nod for generic Rivaroxaban tablets; eyes growth in US Market

Mumbai-based Indoco Remedies Ltd. has secured final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market Rivaroxaban Tablets USP in strengths of 2.5 mg, 10 mg, 15 mg, and 20 mg. The product is the generic equivalent of Janssen Pharmaceuticals' blockbuster anticoagulant, Xarelto, and will be manufactured at Indoco's Verna, Goa facility. The approved Rivaroxaban tablets are bioequivalent and therapeutically equivalent to Xarelto and are indicated for the treatment of venous thromboembolism (VTE). This approval marks another milestone in Indoco's push into the US generics market, one of the most lucrative pharmaceutical markets globally. Commenting on the development, Indoco Remedies' Managing Director Aditi Panandikar said, 'Besides reflecting the capability of Indoco Remedies to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the US.' Indoco Remedies is a fully integrated, research-driven pharmaceutical company with a global footprint, generating over 106 million prescriptions annually in India alone. The company operates 11 manufacturing facilities — seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs) — all of which are approved by top global regulatory agencies including the USFDA and UK-MHRA. With a turnover of $180 million and a workforce of more than 6,000 employees, Indoco is known for popular domestic brands such as Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, and Cital. Internationally, the company partners with large generics players to expand its market reach across multiple geographies. The latest USFDA approval strengthens Indoco's product portfolio in the regulated market and could open up significant revenue opportunities as Rivaroxaban continues to be a widely prescribed oral anticoagulant in the US. Disclaimer: This news article is for informational purposes only and does not constitute investment advice. Investors should consult a qualified financial advisor before making investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store